MeSH tree: C04.557.580
For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment options remain frustratingly limited. A new study from Vanderbilt researchers led by Professor Emerita ...
Feb 27, 2026
0
0
Consumers can protect their skin from damaging ultraviolet (UV) light rays for as little as $40 a year—or as much as $1,400 a year—depending on how expensive a sunscreen they buy and how much of their skin they protect ...
Feb 26, 2026
0
0
CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers. Columbia researchers have now found that a new type ...
Feb 26, 2026
0
1
High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the tumor is removed, making it difficult to treat. Patients with recurrent high-grade astrocytoma typically ...
Feb 26, 2026
0
0
Douglas Grossman, MD, Ph.D., co-leader of the Melanoma Center at Huntsman Cancer Institute at the University of Utah (the U) and professor of dermatology at the U, has helped develop a noninvasive technology that aims to ...
Feb 25, 2026
0
0
A study led by St. Jude Children's Research Hospital assessed cognitive and communication abilities in children treated for the brain tumor ependymoma to understand the impact of treatment better. They found that radiation ...
Feb 23, 2026
0
0
Northwestern Medicine scientists have discovered a potent immunotherapy approach for treating meningiomas, the most common type of primary brain tumor, according to a study published in Nature Communications.
Feb 20, 2026
0
35
Meningioma is the most common type of brain tumor. It does not develop in the brain tissue itself, but on the inside of the meninges, the membranes that surround the brain. In most cases, a meningioma is benign. However, ...
Feb 11, 2026
0
8
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade attack by the body's immune system, a new study shows. Led by researchers at NYU Langone Health and ...
Feb 11, 2026
0
0
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can ...
Feb 11, 2026
0
80
